(b)(4), patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25mm sjm masters series valsalva aortic valved graft was implanted.After the procedure, the patient was diagnosed with coagulopathy due to extended time on bypass.A blood, platelet, and cryoprecipitate transfusion was administered with the patient returning to good hemostasis.It is suspected that the coagulopathy was due to the implant procedure.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.The patient is reported to be discharged.
|